11 – 20 of 22
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Factor IX antibodies and tolerance in hemophilia B in the Nordic countries - The impact of F9 variants and complications
(
- Contribution to journal › Article
- 2021
-
Mark
Treatment outcomes in persons with severe haemophilia B in the Nordic region : The B-NORD study
(
- Contribution to journal › Article
- 2019
-
Mark
Hypertension and cardiovascular diseases in Swedish persons with haemophilia — A longitudinal registry study
(
- Contribution to journal › Article
-
Mark
Joint comorbidities among Swedish carriers of haemophilia : A register-based cohort study over 22 years
(
- Contribution to journal › Article
- 2018
-
Mark
Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays
(
- Contribution to journal › Article
- 2016
-
Mark
Malignancies in Swedish persons with haemophilia : a longitudinal registry study
(
- Contribution to journal › Article
- 2014
-
Mark
Clotting factor level is not a good predictor of bleeding in carriers of haemophilia A and B.
(
- Contribution to journal › Article
-
Mark
Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-Xa assays.
(
- Contribution to journal › Article
- 2011
-
Mark
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
(
- Contribution to journal › Article
-
Mark
Practical Viewpoints on the Diagnosis and Management of Heparin-Induced Thrombocytopenia
(
- Contribution to journal › Article